This renewal application of the MRI, Genetics and Cognitive Precursors of AD and Dementia compares which of 3 approaches for diagnosing Mild Cognitive Impairment (MCI) is best at accurately predicting incident clinical dementia. Of the two primary diagnostic methods currently used, psychometrically defined and clinical determined, application of criteria for psychometrically defined has been most variable. Further, a novel algorithmic method is emerging as an alternative unbiased approach. Using commonly applied clinical tools of cognitive performance and brain structure obtained from baseline and repeat administration of neuropsychological (NP) tests and magnetic imaging resonance (MRI) scans, this proposed project will first determine what profile of cross-sectional or longitudinal neuropsychological tests and threshold performance levels, combined with imaging markers is the most efficacious in predicting progression to dementia, particularly Alzheimer's disease. Another set of analyses will test the algorithmic method. The diagnostic models that emerge from these two sets of analyses will then be compared to diagnoses of MCI using standard clinical criteria to determine which of the three methods best predicts incident dementia. The clinical diagnoses of MCI and dementia are available through a separately funded initiative. Also central to this grant proposal is the inclusion of external seasoned investigators, who will provid their expertise in definition and study of MCI and the factors influencing progression to disease. This effort aims to provide enhanced sensitivity in application of NP and MRI tools to detect subtle impairment at an earlier stage on the preclinical continuum and improved specificity in determining the MCI subtypes most highly associated with AD versus other types of dementia. Increased MCI diagnostic accuracy will enhance opportunity for more effective interventions, which have been largely disappointing to date, and could eventually leading to a delay in the onset or prevention of the clinical expression of AD.

Public Health Relevance

The MRI, Genetics and Cognitive Precursors of AD and Dementia seeks to identify the most effective method and criteria for diagnosis of mild cognitive impairment (MCI) that is best predictive of incident Alzheimer's disease. Current efforts to treat AD have been ineffective because intervention occurs too late in the insidious process. The potential public health relevance of this proposed project is increased accuracy of diagnosis at the preclinical stage, where treatment opportunities may prove to be more successful and prevention is most feasible.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG016495-12
Application #
8545660
Study Section
Special Emphasis Panel (NOIT)
Program Officer
Anderson, Dallas
Project Start
1998-12-01
Project End
2017-05-31
Budget Start
2013-09-01
Budget End
2014-05-31
Support Year
12
Fiscal Year
2013
Total Cost
$609,801
Indirect Cost
$94,712
Name
Boston University
Department
Neurology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Edmonds, Emily C; Delano-Wood, Lisa; Clark, Lindsay R et al. (2015) Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement 11:415-24
Chouraki, Vincent; Beiser, Alexa; Younkin, Linda et al. (2015) Plasma amyloid-? and risk of Alzheimer's disease in the Framingham Heart Study. Alzheimers Dement 11:249-57.e1
Aganj, Iman; Reuter, Martin; Sabuncu, Mert R et al. (2015) Avoiding symmetry-breaking spatial non-uniformity in deformable image registration via a quasi-volume-preserving constraint. Neuroimage 106:238-51
Gupta, Apar; Preis, Sarah R; Beiser, Alexa et al. (2015) Mid-life Cardiovascular Risk Impacts Memory Function: The Framingham Offspring Study. Alzheimer Dis Assoc Disord 29:117-23
Chêne, Geneviève; Beiser, Alexa; Au, Rhoda et al. (2015) Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement 11:310-20
Weinstein, Galit; Preis, Sarah R; Beiser, Alexa S et al. (2014) Cognitive performance after stroke--the Framingham Heart Study. Int J Stroke 9 Suppl A100:48-54
Romero, José Rafael; Preis, Sarah R; Beiser, Alexa et al. (2014) Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 45:1492-4
Ibrahim-Verbaas, Carla A; Fornage, Myriam; Bis, Joshua C et al. (2014) Predicting stroke through genetic risk functions: the CHARGE Risk Score Project. Stroke 45:403-12
Bondi, Mark W; Edmonds, Emily C; Jak, Amy J et al. (2014) Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis 42:275-89
Westwood, Andrew J; Beiser, Alexa; Decarli, Charles et al. (2014) Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy. Neurology 82:1613-9

Showing the most recent 10 out of 112 publications